Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,007 public trials 2,555 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT06929286

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States

Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States

View Trial Details

Recruiting

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

NCT07187778

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

NCT05269381

Conditions: Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +168 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU

NCT06945172

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Clinique La Croix du Sud Quint-Fonsegrives, France

View Trial Details

Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

NCT06785636

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: MemorialCare Orange Coast Medical Center Fountain Valley, California, United States

Cancer and Blood Research Center Los Alamitos, California, United States

University of Colorado Health Aurora, Colorado, United States

Mount Sinai Medical Center Miami, Florida, United States

View all 19 locations

View Trial Details

Recruiting

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

NCT05636111

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

NCT04945642

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
Locations: University of California at Los Angeles / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance

NCT07714018

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Recruiting

Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity

NCT07077239

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: University of California at Los Angeles Los Angeles, California, United States

View Trial Details

Recruiting

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

NCT07644598

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States

View Trial Details

Urogenital Neoplasms

Urogenital Neoplasms trial results

Related conditions